PODDInsulet Corporation

$135.27-59% 1Y

Is it growing?

Good

Growing: revenue growing +29% year on year and earnings up +63% year on year.

2 good, 1 neutral
Revenue trend+29% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings.

Earnings trend+63% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction−0.3 points operating

Trailing-twelve-month operating margin, 16.9% now against 17.2% a year earlier.

All from SEC EDGAR, as of Jun 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearstop 7% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is PODD growing?

Insulet Corporation has grown revenue 28% a year over three years and 25% a year over five, with earnings per share compounding at 81%.

+28%

Revenue growth, 3-year annual rate · Medical Devices median +12% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+25%

Revenue growth, 5-year rate · +28% over three · growth has picked up over the last three years

Earnings per share, 3-year rate
+81%

Earnings per share, 3-year rate · revenue +28% · earnings outgrew revenue: margins or the share count worked for shareholders

Years of annual history on file
17

Years of annual history on file · FY2009 to FY2025, as filed

Details›
Revenue FY2021
$1.10B
Revenue FY2022
$1.31B
Revenue FY2023
$1.70B
Revenue FY2024
$2.07B
Revenue FY2025
$2.71B

Annual income statements as filed with the SEC.